Our findings show that inhibition of CBP/β-catenin interaction suppresses the proliferation of a wide range of STS cell lines and patient-derived cells and promotes cell death, at least in part, via CDC25A downregulation. This evidence concerns the gene CDC25A and telomere syndrome.